How Leica Biosystems and Paige are Removing Barriers to Digital Pathology

To register use the form or link, available below!

Presentation Summary:

In the dynamic realm of healthcare, Digital Pathology and AI are spearheading the future. However, despite the rapid advancements in this space, some laboratories may not fully realize the potential at hand. For many laboratories, integrating Digital Pathology into their established workflow can seem like a daunting task. Recognizing this, Leica Biosystems and Paige are excited to come together, represented by two distinguished experts, to share their insights and discuss the current barriers to Digital Pathology and why Future-Proofing your Digital Pathology Investment will help transform and optimize laboratory workflows across the globe.

Learning Objectives:

 In this webinar, you will discover:

  • Effective methods for overcoming the obstacles associated with decision-making and the seamless implementation of Digital Pathology solutions.
  • Strategies for proactively establishing your Digital Pathology infrastructure and positioning your laboratory for AI integration to optimize productivity.
  • The revolutionary impact of AI on the healthcare industry, along with insights into the barriers faced in anatomical pathology.

Speaker Biographies:

David Klimstra, M.D., is the Founder and Chief Medical Officer at Paige, the first company with an FDA-approved AI product in digital pathology. A renowned expert in tumor pathology of the digestive and neuroendocrine systems, he has published extensively. Dr. Klimstra completed his M.D. and residency at Yale, and a fellowship at Memorial Sloan Kettering Cancer Center, where he worked for 30 years and served as Department Chairman for 10 years.

Robert Monroe, M.D., Ph.D., board-certified in Cytopathology, Anatomic Pathology, and Clinical Pathology with a PhD in Genetics, assumed roles as the VP and Chief Scientific Officer of Oncology at Danaher Diagnostics and CMO at Leica Biosystems in 2022, enhancing their molecular oncology initiatives. His previous roles include CMO at Bio-Techne, BioImagine, a digital pathology startup acquired by Roche, and OncoMDx, a molecular diagnostics lab he co-founded and was later acquired by Core Diagnostics in 2012. Monroe also served as VP at Veracyte and practiced pathology in California, following his medical and residency training at Harvard, UCLA, and Stanford.


Mark Frushone (Global Director of Commercial Development, Digital Pathology at Leica Biosystems) and Ron Williams (Commercial Development Leader, Digital Pathology at Leica Biosystems)

*Leica Biosystems makes no guarantee or assurances that the educational content will in any manner ensure achievement of credits for continuing education. Please check with your own certifying organization(s) and agencies to determine continuing education, licensure, and recertification requirements.

Register Here:

Share This Post

Leave a Reply